Blair William & CO Arrowhead Pharmaceuticals, Inc. Transaction History

Blair William & CO

$31.4 Billion
Q1 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	SELL	$26.2 - $36.08 $62,356 - $85,870	-2,380 Reduced 16.95%	11,660 $313,000
Q2 2023 Aug 11, 2023	SELL	$25.16 - $41.38 $11,322 - $18,621	-450 Reduced 3.11%	14,040 $500,000
Q1 2023 May 12, 2023	SELL	$23.68 - $38.51 $13,473 - $21,912	-569 Reduced 3.78%	14,490 $368,000
Q4 2022 Feb 10, 2023	SELL	$28.0 - $40.56 $52,360 - $75,847	-1,870 Reduced 11.05%	15,059 $610,000
Q3 2022 Nov 09, 2022	SELL	$29.63 - $48.31 $89,038 - $145,171	-3,005 Reduced 15.07%	16,929 $560,000

Q2 2022 Aug 10, 2022	SELL	$27.79 - $50.61 $10,699 - $19,484	-385 Reduced 1.89%	19,934 $702,000
Q1 2022 May 13, 2022	SELL	$39.62 - $69.97 $11,886 - $20,991	-300 Reduced 1.45%	20,319 $934,000
Q4 2021 Feb 14, 2022	SELL	$58.09 - $82.51 $4,821 - $6,848	-83 Reduced 0.4%	20,619 $1.37 Million
Q3 2021 Nov 12, 2021	SELL	$58.38 - $84.96 $12,376 - $18,011	-212 Reduced 1.01%	20,702 $1.29 Million
Q2 2021 Aug 12, 2021	SELL	$62.15 - $90.32 $18,893 - $27,457	-304 Reduced 1.43%	20,914 $1.73 Million
Q1 2021 May 13, 2021	SELL	$61.35 - $90.47 $56,564 - $83,413	-922 Reduced 4.16%	21,218 $1.41 Million
Q4 2020 Feb 09, 2021	SELL	$43.82 - $85.37 $50,393 - $98,175	-1,150 Reduced 4.94%	22,140 $1.7 Million
Q3 2020 Nov 06, 2020	BUY	$33.21 - $51.27 $24,907 - $38,452	750 Added 3.33%	23,290 $1 Million
Q2 2020 Aug 12, 2020	SELL	$26.12 - $43.27 $27,426 - $45,433	-1,050 Reduced 4.45%	22,540 $974,000
Q1 2020 May 11, 2020	SELL	$20.56 - $63.12 $481,576 - $1.48 Million	-23,423 Reduced 49.82%	23,590 $679,000
Q4 2019 Feb 13, 2020	BUY	$28.14 - $73.01 $238,993 - $620,073	8,493 Added 22.05%	47,013 $2.98 Million
Q3 2019 Nov 12, 2019	SELL	$26.26 - $34.86 $15,230 - $20,218	-580 Reduced 1.48%	38,520 $1.09 Million
Q2 2019 Aug 13, 2019	SELL	$17.43 - $28.82 $6,100 - $10,087	-350 Reduced 0.89%	39,100 $1.04 Million
Q1 2019 May 14, 2019	SELL	$12.05 - $20.18 $311,793 - $522,157	-25,875 Reduced 39.61%	39,450 $724,000
Q4 2018 Feb 14, 2019	SELL	$10.74 - $19.7 $24,218 - $44,423	-2,255 Reduced 3.34%	65,325 $811,000
Q3 2018 Nov 13, 2018	BUY	$14.0 - $20.3 $61,740 - $89,523	4,410 Added 6.98%	67,580 $1.3 Million
Q2 2018 Aug 13, 2018	SELL	$6.37 - $14.02 $189,061 - $416,113	-29,680 Reduced 31.97%	63,170 $859,000
Q1 2018 May 15, 2018	BUY	$3.72 - $7.64 $345,402 - $709,374	92,850 New	92,850 $669,000

Others Institutions Holding ARWR

# of Institutions

296

Shares Held

88.5M

Call Options Held

905K

Put Options Held

387K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.71B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

News

Stay updated on Blair William & CO with notifications on news.

Account